Study to Assess the Incidence of Hemolysis, Safety, and Efficacy of Tafenoquine (SB-252263, WR238605) Versus Primaquine in Subjects With Plasmodium Vivax Malaria
Clinical trial NCT02216123 · COMPLETED
Trial details
- NCT number
- NCT02216123
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-30
- Primary completion
- 2016-11-04
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.